Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Origuchi

Showing results (191-200 of 227) with videos related to

Pageof 23
Sort By:
Modern Rheumatology|October 23, 2024
The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitisMasatoshi Kanda, Ken Nagahata, Masafumi Moriyama, et al.
Clinical and Experimental Rheumatology|July 8, 2016
Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practiceShin-Ya Kawashiri, Ayako Nishino, Takahisa Suzuki, et al.
Clinical and Experimental Rheumatology|January 28, 2021
Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related diseaseSosuke Tsuji, Naoki Iwamoto, Yoshiro Horai, et al.
Arthritis Research & Therapy|November 22, 2018
Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in JapanYushiro Endo, Tomohiro Koga, Midori Ishida, et al.
Modern Rheumatology|April 11, 2014
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositisYoshiro Horai, Tomohiro Koga, Keita Fujikawa, et al.
Clinical and Experimental Rheumatology|October 7, 2020
Next-generation sequencing of the whole MEFV gene in Japanese patients with familial Mediterranean fever: a case-control association studyTomohiro Koga, Shuntaro Sato, Hiroyuki Mishima, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2018
Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid ArthritisTakahisa Suzuki, Shoichi Fukui, Kunihiko Umekita, et al.
Modern Rheumatology|December 29, 2015
Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritisNaoki Iwamoto, Shoichi Fukui, Masataka Umeda, et al.
Kidney International|August 20, 2010
Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritisTakako Saeki, Shinichi Nishi, Naofumi Imai, et al.
Clinical and Experimental Rheumatology|April 14, 2018
Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial functionShin-Ya Kawashiri, Ayako Nishino, Takashi Igawa, et al.
Pageof 23

Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
Modern Rheumatology|October 23, 2024
The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitisMasatoshi Kanda, Ken Nagahata, Masafumi Moriyama, et al.
Clinical and Experimental Rheumatology|July 8, 2016
Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practiceShin-Ya Kawashiri, Ayako Nishino, Takahisa Suzuki, et al.
Clinical and Experimental Rheumatology|January 28, 2021
Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related diseaseSosuke Tsuji, Naoki Iwamoto, Yoshiro Horai, et al.
Arthritis Research & Therapy|November 22, 2018
Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in JapanYushiro Endo, Tomohiro Koga, Midori Ishida, et al.
Modern Rheumatology|April 11, 2014
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositisYoshiro Horai, Tomohiro Koga, Keita Fujikawa, et al.
Clinical and Experimental Rheumatology|October 7, 2020
Next-generation sequencing of the whole MEFV gene in Japanese patients with familial Mediterranean fever: a case-control association studyTomohiro Koga, Shuntaro Sato, Hiroyuki Mishima, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2018
Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid ArthritisTakahisa Suzuki, Shoichi Fukui, Kunihiko Umekita, et al.
Modern Rheumatology|December 29, 2015
Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritisNaoki Iwamoto, Shoichi Fukui, Masataka Umeda, et al.
Kidney International|August 20, 2010
Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritisTakako Saeki, Shinichi Nishi, Naofumi Imai, et al.
Clinical and Experimental Rheumatology|April 14, 2018
Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial functionShin-Ya Kawashiri, Ayako Nishino, Takashi Igawa, et al.
Pageof 23